Marijuana Stocks Are Soaring Friday on Anticipation Trump Could Soon Make This Change

Core Insights - Cannabis stocks experienced significant gains following reports that President Trump may soon reclassify marijuana to a less dangerous substance, with Tilray Brands (TLRY) rising nearly 30% and Canopy Growth (CGC) increasing by almost 40% [1][6] Industry Impact - The potential reclassification of marijuana from a Schedule I drug to a Schedule III drug would alleviate financial and regulatory burdens on cannabis producers, potentially enhancing financial access for these companies [3][5] - Currently, marijuana remains illegal under federal law, despite its legalization in many states for medicinal or recreational use, which limits research and imposes stricter penalties [4] - A lower classification would benefit the cannabis industry by reducing taxes and easing banking regulations, allowing for greater use of credit cards and other financial services [5]